A Rare Case of Myocarditis Causing Interventricular Communication and Acute Heart Failure
Mounaouir Karim
Ibn Rochd University Hospital, Casablanca 20250, Morocco.
Nachid Mohammed *
Ibn Rochd University Hospital, Casablanca 20250, Morocco.
Mehdi Rochd
Ibn Rochd University Hospital, Casablanca 20250, Morocco.
Benhar Ismail
Ibn Rochd University Hospital, Casablanca 20250, Morocco.
Meryem Haboub
Ibn Rochd University Hospital, Casablanca 20250, Morocco.
Salim Arous
Ibn Rochd University Hospital, Casablanca 20250, Morocco.
Ghali Mohamed Bennouna
Ibn Rochd University Hospital, Casablanca 20250, Morocco.
Abdenasser Drighil
Ibn Rochd University Hospital, Casablanca 20250, Morocco.
Habbal Rachida
Ibn Rochd University Hospital, Casablanca 20250, Morocco.
*Author to whom correspondence should be addressed.
Abstract
Myocarditis is a rare but potentially life-threatening condition that involves inflammation of the heart muscle. It can present with a wide range of clinical manifestations, including acute heart failure, arrhythmias, and ventricular dysfunction. In rare cases, myocarditis can lead to the formation of interventricular communication, which is an abnormal communication between the left and right ventricles. We present a case report of a 31-year-old male who presented to the emergency department with acute heart failure and was subsequently diagnosed with myocarditis causing interventricular communication.
Keywords: Myocarditis, interventricular communication, heart failure, diagnosis, management, outcome
How to Cite
References
Batra AS, Lewis AB. Acute myocarditis. Current Opinion in Pediatrics. 2001 1;13(3):234-9.
Sotiris S. Isolated Form of Left Ventricular Non-compaction Cardiomyopathy (LVNC) as a Rare Cause of Heart Failure. InCurrent Perspectives on Cardiomyopathies. 2018 ;26. IntechOpen.
Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Charron P. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. European Heart Journal. 2013 ;34(33) :2636-2648.
Shabtaie SA, Garan AR, Topkara VK. Interventricular Septal Defect. In Mechanical Circulatory Support. 2019;169-176. Springer.
Ammirati E, Veronese G, Brambatti M, Merlo M, Cipriani M, Potena L, Caforio A LP. Fulminant versus acute nonfulminant myocarditis in patients with left ventricular systolic dysfunction. Journal of the American College of Cardiology. 2018;7 1(4) :386-395.
Bhardwaj A, Tanavde V. Elevated B-type natriuretic peptide in acute myocarditis. Cardiology in the Young. 2020;30(11) : 1617-1619.
Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio Jr JJ, Popp RL. Myocarditis: a histopathologic definition and classification. The American Journal of Cardiovascular Pathology. 1987;1(1):3-14.
Friedrich, M. G., Sechtem, U., Schulz-Menger J, Holmvang G, Alakija P., Cooper LT, Mahrholdt H. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. Journal of the American College of Cardiology. 2009;53(17) :1475-1487.
Larsson CA, Ghassem-Zadeh SA, DeMaria AN. Hemodynamically significant interventricular septal defect due to acute myocarditis. Journal of the American Society of Echocardiography. 2003; 16(10) :1086-1089.
Barbetseas J, Papalois A, Korovesis S, Stefanadis C. Left ventricular outflow tract obstruction due to an acquired interventricular septal defect in a patient with myocarditis: a case report. European Journal of Echocardiography. 2005;6(1) : 74-77.
Mirza KZ, Chu LF, Rorick N, Okunrintemi, V, Figueredo VM, Konecny T. Septal rupture complicating acute myocarditis: a rare and life-threatening disorder. Journal of the American College of Cardiology. 2018;71(11_Supplement), A2353.
Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, Sechtem, U. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation. 2006;114(15) : 1581-1590.
Assomull RG, Lyne JC, Keenan N, Gulati, A, Bunce NH, Davies SW, Pennell, D. J. The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. European Heart Journal. 2007;28(10):1242-1249.
Kociol RD, Cooper LT, Fang JC, Moslehi J J, Pang PS, Sabe MA, Dries DL. Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association. Circulation. 2017;136(16): e133-e154.
Schmitt-Grohe S, Selton-Suty C, Sevestre-Pietri M, et al. Features and outcomes of 899 patients with drug-induced eosinophilic myocarditis registered in the prospective multicenter DRUG-REACT-MI Registry. Eur J Heart Fail. 2013;15(6):703-710.
Luetkens JA, Faron A, Isaak A, Dabir D, Kuetting DLR, Feisst A, Maintz D. Comparison of original and 2018 Lake Louise criteria for diagnosis of acute myocarditis: results of a validation cohort. Radiology. 2018;288(2):426- 432.